A new law backed by the University of California gives cancer patients access to biomarker testing so targeted therapies can be used to fight their cancer.
IN THE NEWS: Multiple sclerosis (MS), a debilitating condition that can affect the brain, spinal cord and optic nerves, impacts almost 1 million Americans. Treatments for the more common but unpredictable relapsing-remitting MS have expanded in recent years. Those for progressive MS, however, have lagged behind. UCI Health multiple sclerosis…
Orange, Calif. ― UCI Health is pleased to announce Dr. Shalini Shah has been appointed as the president of the Orange County Medical Association (OCMA), marking a historic moment for UCI Health. Shah is the first physician from UCI Health to serve as the president of OCMA. Dr. Phyllis Agran…
A multicenter study evaluated a protein drug (INBRX-101), developed to improve care for people with alpha-1 antitrypsin deficiency, and showed the therapy is quite safe.
Orange, Calif. — UCI Medical Center has once again achieved the Baby-Friendly designation for adhering to the highest standards of care for breastfeeding mothers and their babies. The prestigious international certification from Baby-Friendly USA is granted after a rigorous, on-site review process. The organization’s standards are built on the Ten…
A newly discovered hormone explains why females can maintain bone density during lactation, when calcium is stripped away to make milk. This discovery could one day have applications to treating fractures, osteoporosis, and other bone diseases.
Orange, Calif. — UCI Medical Center has once again achieved the Baby-Friendly designation for adhering to the highest standards of care for breastfeeding mothers and their babies. The prestigious international certification from Baby-Friendly USA is granted after a rigorous, on-site review process. The organization’s standards are built on the Ten…
